Regulation of β-tubulin isotypes by micro-RNA 100 in MCF7 breast cancer cells

microRNA, Cell Cycle, and Human Breast Cancer

(2010) Zuoren Yu et al.   AMERICAN JOURNAL OF PATHOLOGY

MiRNAs as biomarkers and therapeutic targets in cancer☆

(2010) Helen M Heneghan et al.   CURRENT OPINION IN PHARMACOLOGY

The miR-200 family controls  -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients

(2010) S. Leskela et al.   ENDOCRINE-RELATED CANCER

A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian Cancer

(2010) Ankur K. Nagaraja et al.   MOLECULAR ENDOCRINOLOGY

Molecular Basis for Class V β-Tubulin Effects on Microtubule Assembly and Paclitaxel Resistance

(2009) Rajat Bhattacharya et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents

(2009) D. R. Cochrane et al.   MOLECULAR CANCER THERAPEUTICS

A minor β-tubulin essential for mammalian cell proliferation

(2008) Rajat Bhattacharya et al.   CELL MOTILITY AND THE CYTOSKELETON

β‐tubulin isotype classes II and V expression patterns in nonsmall cell lung carcinomas

(2008) Valeria Cucchiarelli et al.   CELL MOTILITY AND THE CYTOSKELETON